GSMA Announces First Speakers for Mobile 360 Series – Middle East and North Africa
The GSMA today announced the first speakers for its Mobile 360 Series – Middle East and North Africa (MENA) conference taking place 9-10 October in Dubai, United Arab Emirates. The two-day event, which is now in its fifth year, will bring together senior-level delegates from across the region to debate and discuss the key opportunities and challenges facing the mobile industry. The programme includes topics such as the Internet of Things, 5G, digital identity, artificial intelligence and more.
“Through long-term investment, mobile technology is radically transforming the lives of businesses and citizens across this diverse region and having a significant economic and social impact,” said Michael O’Hara, Chief Marketing Officer, GSMA. “This year’s Mobile 360 – MENA event has an amazing line-up of high-profile speakers who will address the key issues shaping mobile in the region, now and in the immediate future. We look forward to welcoming attendees to this year’s show.”
The first speakers confirmed for the event include:
- Ulugbek Yuldashev, Founder, Awok.com
- Daddy Mukadi, Chief Regulatory Officer, Bharti Airtel Africa
- Faisal Al Bannai, Founder and CEO, DarkMatter
- Osman Sultan, CEO, Du
- Matias Silanpaa, EMEA Director of Growth and Operator Partnerships, Facebook
- Mats Granryd, Director General, GSMA
- Nasser Kettani, CTO Middle East and Africa, Microsoft
- Dr. Atef Helmy, Senior Advisor, Board of Directors, Orange Middle East and Africa
- Abdulrahman Tarabzouni, CEO and MD, STV
- Nazar Arabi, CSO, Sudatel Group
- Firat Yaman Er, CSO, Turk Telekom
- Ziad Shatara, CEO, Umniah
- Mikkel Vinter, Founder and CEO, Virgin Mobile Middle East
- Fadi Ghandour, Chairman, Wamda Group
- Diana Baddar, Head of Partnerships MENA and Turkey, YouTube
- Scott Gegenheimer, CEO of Operations, Zain Group
Mobile 360 – MENA includes a mix of keynote presentations, panel discussions, workshops and in-depth case studies aimed at senior-level decision makers across the region. The event, which regularly attracts senior-level leaders from mobile network operators, network infrastructure vendors, governments and regulatory bodies, and content providers, provides delegates the opportunity to hear insights from senior leaders across the industry. This year’s agenda includes perspectives from across the ecosystem, with sessions such as ‘Smart Cities and Connected Cars,’ ‘The Case for Dynamic Governance and Regulatory Modernisation’ and ‘Financial Inclusion and E-Commerce’. This year, the event also includes a dedicated session on North Africa and a new Start-ups Showcase.
Mobile 360 – MENA will be co-located once more with GITEX at the Dubai World Trade Centre in Dubai. The event will be held in the new Za'abeel Hall 6, close to Gulfcomms, within the Dubai World Trade Centre. Industry leaders supporting the event include Etisalat (Host Sponsor), Bank of Khartoum (Gold Sponsor), Huawei (Global Industry Supporter Sponsor), Global Certification Forum (Showcase Sponsor) and Mobile Arts (Supporting Sponsor).
For further information on Mobile 360 – MENA, including sponsorship opportunities, please visit www.mobile360series.com/mena/. Follow developments and updates on Mobile 360 – MENA (#M360MENA) on Twitter @GSMA, on Facebook www.facebook.com/Mobile360Series and LinkedIn on www.linkedin.com/company/gsma-mobile-360-series. Download the event app for further information: www.mobile360series.com/app/.
About the GSMA
The GSMA represents the interests of mobile operators worldwide, uniting nearly 800 operators with more than 300 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces industry-leading events such as Mobile World Congress, Mobile World Congress Shanghai, Mobile World Congress Americas and the Mobile 360 Series of conferences.
For more information, please visit the GSMA corporate website at www.gsma.com. Follow the GSMA on Twitter: @GSMA.
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Shell, bio-bean and Coffee-Drinkers Collaborate to Help Power London’s Buses20.11.2017 00:01 | Pressemelding
Shell and bio-bean announce that together they are helping to power some of London’s buses using a biofuel made partly from waste coffee grounds. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171119005060/en/ Shell and bio-bean announce that together they are helping to power some of London's buses using a biofuel made partly from waste coffee grounds (Photo: Business Wire) The B20 biofuel contains a 20% bio-component which contains part coffee oil. The biofuel is being added to the London bus fuel supply chain and will help to power some of the buses; without need for modification. Biofuel provides a cleaner, more sustainable energy solution for buses across London’s network by decreasing emissions1. “Our Coffee Logs have already become the fuel of choice for households looking for a
Samsung Bioepis Receives Regulatory Approval for Europe's First Trastuzumab Biosimilar, ONTRUZANT®19.11.2017 22:21 | Pressemelding
Samsung Bioepis Co., Ltd. today announced the European Commission’s (EC) marketing authorization of ONTRUZANT ® , a biosimilar referencing Herceptin ® (trastuzumab), for the treatment of early breast cancer, metastatic breast cancer and metastatic gastric cancer. ONTRUZANT ® is the first trastuzumab biosimilar to receive regulatory approval in Europe. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171119005066/en/ Christopher Hansung Ko, President & CEO of Samsung Bioepis. (Photo: Business Wire) The EC approval of ONTRUZANT ® applies to all 28 European Union (EU) member states and the European Economic Area (EEA) member states of Norway, Iceland and Liechtenstein. ONTRUZANT ® will be commercial
Cancer Patients, Survivors, Supporters and Caregivers Undertake UAE's First Relay for Life19.11.2017 16:31 | Pressemelding
Sharjah, the third largest of the United Arab Emirate’s seven emirates, was the host for the MENA region’s first ever ‘Global Relay for Life,’ (RFL) a 24-hour walkathon that is the biggest fundraising event for cancer in the world. Conducted in conjunction with the American Cancer Society, the event was organised by Friends of Cancer Patients (FoCP), a non-profit organisation that supports cancer patients and their families. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171119005048/en/ During MENA's first Global Relay For Life walkathon - Source: Friends of Cancer Patients Taking place November 17-18 at the American University Sharjah, the inaugural UAE RFL saw more than 2,000 relayers participating in the overnight event, with a large number of individuals and institutions involved including 52 sch
New Data Show Benefit of Tagrisso in Patients with EGFR-mutated Non-small Cell Lung Cancer and Central Nervous System Metastases18.11.2017 23:00 | Pressemelding
AstraZeneca today presented new data from a subgroup analysis of the Phase III FLAURA trial, which explored osimertinib as 1st-line therapy in patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC). Results presented at the ESMO Asia 2017 Congress in Singapore showed that patients with central nervous system (CNS) metastases at baseline had a higher objective response rate with their brain metastasis and suggest a lower risk of CNS progression when treated with osimertinib, a third-generation, irreversible EGFR tyrosine kinase inhibitor (TKI), versus current standard-of-care EGFR-TKIs (erlotinib or gefitinib) [Abstract LBA5].1 The analysis included patients with ≥1 measurable and/or non-measurable CNS lesion present on baseline scan (as assessed by blinded independent central review), accounting for 23
New England Journal of Medicine Publishes Results of Phase III FLAURA Trial in the 1st-Line Treatment of EGFR-mutated Non-small Cell Lung Cancer18.11.2017 18:20 | Pressemelding
AstraZeneca today announced that the New England Journal of Medicine has published the positive results from the Phase III FLAURA trial which provide data for Tagrisso’s (osimertinib) use in the 1st-line treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC).1 The trial showed a statistically significant, clinically meaningful progression-free survival (PFS) advantage for osimertinib, a third-generation, irreversible EGFR tyrosine kinase inhibitor (TKI), compared with current 1st-line EGFR-TKIs, erlotinib or gefitinib.1 This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171118005044/en/ Dr. Suresh S. Ramalingam, Principal Investigator of the FLAURA trial, from the Winship Cancer Institute
Much-Anticipated CHTF 2017 Top 10 Products Are Unveiled18.11.2017 09:11 | Pressemelding
The 19th China Hi-Tech Fair (CHTF 2017), with the theme of “Innovation-Driven Development and Supply Quality Upgrade”, is taking place from November 16 to 21 at Shenzhen Convention and Exhibition Center. On the afternoon of November 10, the CHTF 2017 Top 10 Products were unveiled at the awards ceremony by Mr. Gao Zimin, Vice Mayor of Shenzhen City. A total of 322 entries competed for the honor Top 10 Products, and the voting lasted nearly 3 months. 60 candidate products in the fields of new energy, 3D print, flexible display, life sciences, unmanned vehicles and AI were shortlisted by the organizer, experts and media representatives and went for open voting online. The final Top 10 Products all represent the most advanced technologies in their respective sectors: the water-making device that can make water out of air, the smart sportswear that can monitor heartbeat and other
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom